Table 1.
Basic patient characteristics and results of hormonal testing in FHA-PCOM and PCOS-D patients. Data are presented as mean ± SD.
| FHA-PCOM | PCOS-D | p | |
|---|---|---|---|
| Age (years) | 25.5 ± 4.7 | 25.5 ± 4.7 | 1.000 |
| BMI (kg/m2) | 26.4 ± 6.3 | 26.3 ± 6.2 | 0.983 |
| TSH (IU/mL) | 1.7 ± 0.7 | 2.0 ± 1.0 | 0.053 |
| FSH (mIU/mL) | 5.2 ± 2.1 | 5.1 ± 1.9 | 0.930 |
| LH (mIU/mL) | 3.6 ± 3.1 | 8.8 ± 5.6 | <0.001 |
| LH : FSH ratio | 0.7 ± 0.5 | 1.7 ± 1.0 | <0.001 |
| Prolactin (ng/mL) | 10.2 ± 4.1 | 13.5 ± 7.7 | 0.036 |
| Estradiol (pg/mL) | 23.0 ± 14.1 | 53.3 ± 19.4 | <0.001 |
| Testosterone (ng/mL) | 0.22 ± 0.12 | 0.38 ± 0.09 | <0.001 |
| Androstenedione (ng/mL) | 2.0 ± 1.1 | 2.7 ± 0.9 | 0.003 |
| DHEAS (µg/mL) | 2.2 ± 1.1 | 2.5 ± 0.8 | 0.048 |
| SHBG (nmol/L) | 81.8 ± 41.8 | 49.8 ± 37.4 | <0.001 |
| AMH (ng/mL) | 6.9 ± 3.8 | 8.4 ± 5.1 | 0.071 |